<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Kardiochir Torakochirurgia Pol</journal-id><journal-id journal-id-type="iso-abbrev">Kardiochir Torakochirurgia Pol</journal-id><journal-id journal-id-type="publisher-id">KITP</journal-id><journal-title-group><journal-title>Kardiochirurgia i Torakochirurgia Polska = Polish Journal of Cardio-Thoracic Surgery</journal-title></journal-title-group><issn pub-type="ppub">1731-5530</issn><issn pub-type="epub">1897-4252</issn><publisher><publisher-name>Termedia Publishing House</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26336410</article-id><article-id pub-id-type="pmc">4283870</article-id><article-id pub-id-type="publisher-id">23071</article-id><article-id pub-id-type="doi">10.5114/kitp.2014.43839</article-id><article-categories><subj-group subj-group-type="heading"><subject>Cardiac Surgery</subject></subj-group></article-categories><title-group><article-title>Transfusion of blood products in off-pump coronary artery bypass and conventional coronary artery revascularization. A prospective randomized study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Walczak</surname><given-names>Maciej</given-names></name><xref ref-type="aff" rid="AF0001">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Urbanowicz</surname><given-names>Tomasz Kamil</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Tomczyk</surname><given-names>Jadwiga</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Camacho</surname><given-names>Estillita</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Ligowski</surname><given-names>Marcin</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Stefaniak</surname><given-names>Sebastian</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Jemielity</surname><given-names>Marek</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib></contrib-group><aff id="AF0001"><label>1</label>Cardiac Surgery and Transplantology Department, Chair of Cardio-Thoracic Surgery, Poznan University of Medical Sciences, Poland</aff><aff id="AF0002"><label>2</label>Cardiac Surgery Department, University Hospital of Lord's Transfiguration, Poznan, Poland</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Tomasz Urbanowicz, MD, PhD, D&#x00142;uga 1/2, 61-848 Pozna&#x00144;, Poland. tel. +48 61 854 92 33. e-mail: <email xlink:href="tomasz.urbanowicz@skpp.edu.pl">tomasz.urbanowicz@skpp.edu.pl</email></corresp></author-notes><pub-date pub-type="epub"><day>29</day><month>6</month><year>2014</year></pub-date><pub-date pub-type="ppub"><month>6</month><year>2014</year></pub-date><volume>11</volume><issue>2</issue><fpage>136</fpage><lpage>139</lpage><history><date date-type="received"><day>01</day><month>1</month><year>2014</year></date><date date-type="rev-recd"><day>13</day><month>1</month><year>2014</year></date><date date-type="accepted"><day>01</day><month>4</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Introduction</title><p>There has been a growing interest in off-pump coronary artery bypass (OPCAB) grafting in recent years. Beating-heart surgery is believed to be less invasive as it allows the side effects of extracorporeal circulation to be avoided.</p></sec><sec id="st2"><title>The aim of the study</title><p>The aim of the study was to compare blood product transfusion rates between two groups of patients undergoing surgery for ischemic heart disease with either the off-pump technique or using cardiopulmonary bypass (CPB).</p></sec><sec id="st3"><title>Material and methods</title><p>There were 152 patients enrolled in the prospective randomized study. All procedures were elective. There were 84 patients (62 men and 20 women) at the mean age of 63.74 &#x000b1; 7 years who underwent OPCAB (group I), and 68 patients (54 men and 14 women) at the mean age of 63.51 &#x000b1; 6 years who underwent cardiopulmonary bypass (group II).</p></sec><sec id="st4"><title>Results</title><p>There were no perioperative deaths. The mean number of grafts was 2.27 &#x000b1; 0.3 (OPCAB group) and 2.63 &#x000b1; 0.6 (CPB group) (<italic>p</italic> &#x0003c; 0.05). The mean number of packed red blood cells transfused in the OPCAB group was 2.31 &#x000b1; 0.18 units/patient and 3.94 &#x000b1; 0.30 units/patient in the CPB group (<italic>p</italic> &#x0003c; 0.05). The mean number of fresh frozen plasma units transfused was 1.13 &#x000b1; 0.13 in the OPCAB group vs. 1.57 &#x000b1; 0.15 in the CPB group (<italic>p</italic> &#x0003c; 0.05). There were 12 patients (14%) in the OPCAB group who had no transfusion.</p></sec><sec id="st5"><title>Conclusions</title><p>One of the most important advantages of the OPCAB technique is that it makes it possible to reduce the rate of blood product transfusions.</p></sec></abstract><trans-abstract xml:lang="pl"><sec id="st6"><title>Wst&#x00119;p</title><p>W ostatnich latach coraz cz&#x00119;&#x0015b;ciej wprowadza si&#x00119; do leczenia chirurgicznego choroby wie&#x00144;cowej zabieg pomostowania aortalno-wie&#x00144;cowego bez u&#x0017c;ycia kr&#x00105;&#x0017c;enia pozaustrojowego (<italic>off-pump coronary artery bypass</italic> &#x02013; OPCAB). Zabieg przeprowadzany na bij&#x00105;cym sercu uwa&#x0017c;a si&#x00119; za mniej inwazyjny, poniewa&#x0017c; pozwala unikn&#x00105;&#x00107; efekt&#x000f3;w ubocznych zwi&#x00105;zanych ze stosowaniem kr&#x00105;&#x0017c;enia pozaustrojowego.</p></sec><sec id="st7"><title>Celem badania</title><p>Celem badania by&#x00142;o por&#x000f3;wnanie ilo&#x0015b;ci przetaczanych preparat&#x000f3;w krwi w dw&#x000f3;ch grupach pacjent&#x000f3;w operowanych z powodu choroby niedokrwiennej serca przy u&#x0017c;yciu techniki pomostowania aortalno-wie&#x00144;cowego bez u&#x0017c;ycia kr&#x00105;&#x0017c;enia pozaustrojowego lub z u&#x0017c;yciem kr&#x00105;&#x0017c;enia pozaustrojowego (<italic>cardiopulmonary bypass</italic> &#x02013; CPB).</p></sec><sec id="st8"><title>Materia&#x00142; i metody</title><p>Do prospektywnego badania z randomizacj&#x00105; zakwalifikowano 152 pacjent&#x000f3;w. Wszystkie zabiegi przeprowadzono w trybie elektywnym. Grupa I sk&#x00142;ada&#x00142;a si&#x00119; z 84 os&#x000f3;b (64 m&#x00119;&#x0017c;czyzn i 20 kobiet), w &#x0015b;rednim wieku 63,74 &#x000b1; 7 lat, kt&#x000f3;re poddano zabiegowi z u&#x0017c;yciem techniki OPCAB, a grup&#x00119; II tworzy&#x00142;o 60 os&#x000f3;b (54 m&#x00119;&#x0017c;czyzn i 14 kobiet), w &#x0015b;rednim wieku 63,51 &#x000b1; 6 lat, kt&#x000f3;re poddano zabiegowi z u&#x0017c;yciem p&#x00142;ucoserca (CPB).</p></sec><sec id="st9"><title>Wyniki</title><p>&#x0015a;r&#x000f3;doperacyjnie i we wczesnym okresie pooperacyjnym nie obserwowano przypadk&#x000f3;w &#x0015b;miertelnych. &#x0015a;rednia liczba wykonanych pomost&#x000f3;w wynios&#x00142;a 2,27 &#x000b1; 0,3 (grupa OPCAB) i 2,63 &#x000b1; 0,6 (grupa operacji w kr&#x00105;&#x0017c;eniu pozaustrojowym/grupa CPB) (<italic>p</italic> &#x0003c; 0,05). &#x0015a;rednia liczba jednostek koncentratu krwinek czerwonych podanych w grupie OPCAB wynios&#x00142;a 2,31 &#x000b1; 0,18 jednostek na pacjenta, a w grupie CPB &#x02013; 3,94 &#x000b1; 0,30 jednostek na pacjenta (<italic>p</italic> &#x0003c; 0,05). &#x0015a;rednia liczba jednostek &#x0015b;wie&#x0017c;o mro&#x0017c;onego osocza wynios&#x00142;a 1,13 &#x000b1; 0,13 w grupie OPCAB i 1,57 &#x000b1; 0,15 w grupie CPB (<italic>p</italic> &#x0003c; 0,05). U 12 pacjent&#x000f3;w (14%) w grupie OPCAB nie wykonano transfuzji.</p></sec><sec id="st10"><title>Wnioski</title><p>Istotn&#x00105; zalet&#x00105; techniki OPCAB jest zwi&#x00105;zana z ni&#x00105; mo&#x0017c;liwo&#x0015b;&#x00107; zmniejszenia cz&#x00119;sto&#x0015b;ci transfuzji preparat&#x000f3;w krwi.</p></sec></trans-abstract><kwd-group><kwd>myocardial revascularization</kwd><kwd>OPCAB</kwd><kwd>CPB</kwd><kwd>CABG</kwd><kwd>blood products</kwd><kwd>transfusion</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="S0001"><title>Introduction</title><p>Cardiovascular diseases are the leading cause of death in Poland. Among them, ischemic heart disease poses one of the largest challenges [<xref rid="CIT0001" ref-type="bibr">1</xref>].</p><p>Recent years have seen a growing interest in off-pump coronary artery bypass surgery. The majority of cardiac procedures are performed on cardiopulmonary bypass, with blood transfusions being part of the procedure [<xref rid="CIT0002" ref-type="bibr">2</xref>]. As the extracorporeal circulation causes many side effects involving blood components, the restoration of hemoglobin concentration by means of transfusion is almost always essential [<xref rid="CIT0003" ref-type="bibr">3</xref>]. The majority of heart surgery complications are reported to be related to cardiopulmonary bypass [<xref rid="CIT0004" ref-type="bibr">4</xref>]. Systemic inflammatory response syndrome (SIRS) is usually self-limiting and may involve most organs [<xref rid="CIT0005" ref-type="bibr">5</xref>, <xref rid="CIT0006" ref-type="bibr">6</xref>].</p><p>Hemostatic disturbances secondary to CPB may cause such serious complications as disseminated intravascular coagulation (DIC) [<xref rid="CIT0007" ref-type="bibr">7</xref>, <xref rid="CIT0008" ref-type="bibr">8</xref>].</p></sec><sec sec-type="materials|methods" id="S0002"><title>Material and methods</title><p>There were 152 patients (118 men and 34 women) at the mean age of 63 &#x000b1; 14 years enrolled in the study. The patients were divided into the OPCAB group and the CPB group. The OPCAB group included 84 patients (64 men and 20 women) at the mean age of 64 &#x000b1; 7 years and the CPB group included 68 patients (54 men and 14 women) at the mean age of 63 &#x000b1; 6 years. The mean preoperative left ventricular ejection fraction was 53 &#x000b1; 9% and 51 &#x000b1; 8%, respectively. Demographic and clinical data are presented in <xref ref-type="table" rid="T0001">Table I</xref>. All procedures were performed as a result of stable angina pectoris. Concomitant valvular pathology was the exclusion criterion. Preoperative laboratory tests showed no statistically significant difference between the groups. The serum hemoglobin concentration was 8.70 &#x000b1; 1.03 mmol/L in the OPCAB group vs. 8.78 &#x000b1; 0.70 in the CPB group. The mean hematocrit values were 0.41 &#x000b1; 0.05 in the OPCAB group vs. 0.42 &#x000b1; 0.03 in the CPB group, ns. There was no difference in serum platelet concentration, which was 251.42 &#x000b1; 74.01 G/L in the OPCAB group vs. 228.04 &#x000b1; 59.78 G/L in the CPB group.
</p><table-wrap id="T0001" position="float"><label>Tab. I</label><caption><p>Demographical and perioperative data</p></caption><table frame="hsides" rules="rows"><thead><tr><th align="left" rowspan="1" colspan="1">Data</th><th align="center" rowspan="1" colspan="1">OPCAB group <italic>n</italic> = 84</th><th align="center" rowspan="1" colspan="1">CABG group <italic>n</italic> = 68</th><th align="center" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>Demographical</bold>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Age</td><td align="center" rowspan="1" colspan="1">64 &#x000b1; 7</td><td align="center" rowspan="1" colspan="1">63 &#x000b1; 6</td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Gender (M/F)</td><td align="center" rowspan="1" colspan="1">64/20</td><td align="center" rowspan="1" colspan="1">54/14</td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">Risk factors</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;DM</td><td align="center" rowspan="1" colspan="1">14 (17%)</td><td align="center" rowspan="1" colspan="1">11 (16%)</td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Stroke</td><td align="center" rowspan="1" colspan="1">2 (2%)</td><td align="center" rowspan="1" colspan="1">2 (3%)</td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Peripheral disease</td><td align="center" rowspan="1" colspan="1">4 (5%)</td><td align="center" rowspan="1" colspan="1">4 (6%)</td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;COPD</td><td align="center" rowspan="1" colspan="1">7 (8%)</td><td align="center" rowspan="1" colspan="1">5 (7%)</td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Smoking history</td><td align="center" rowspan="1" colspan="1">16 (19%)</td><td align="center" rowspan="1" colspan="1">12 (17%)</td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Arterial hypertension</td><td align="center" rowspan="1" colspan="1">42 (50%)</td><td align="center" rowspan="1" colspan="1">31 (45%)</td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Clinical</bold>
</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Vessel disease</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;LMCA</td><td align="center" rowspan="1" colspan="1">10 (12%)</td><td align="center" rowspan="1" colspan="1">8 (12%)</td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;2 vessels disease</td><td align="center" rowspan="1" colspan="1">22 (26%)</td><td align="center" rowspan="1" colspan="1">24 (34%)</td><td align="center" rowspan="1" colspan="1">
<italic>p</italic> &#x0003c; 0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;3 vessel disease</td><td align="center" rowspan="1" colspan="1">52 (62%)</td><td align="center" rowspan="1" colspan="1">36 (53%)</td><td align="center" rowspan="1" colspan="1">
<italic>p</italic> &#x0003c; 0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">LVEF</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;preoperatively</td><td align="center" rowspan="1" colspan="1">57 &#x000b1; 4%</td><td align="center" rowspan="1" colspan="1">53 &#x000b1; 6%</td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;postoperatively</td><td align="center" rowspan="1" colspan="1">59 &#x000b1; 6%</td><td align="center" rowspan="1" colspan="1">54 &#x000b1; 7%</td><td align="center" rowspan="1" colspan="1">ns</td></tr><tr><td align="left" rowspan="1" colspan="1">Surgery</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No of grafts</td><td align="center" rowspan="1" colspan="1">2.27 &#x000b1; 0.3%</td><td align="center" rowspan="1" colspan="1">2.63 &#x000b1; 0.6%</td><td align="center" rowspan="1" colspan="1">ns</td></tr></tbody></table></table-wrap><p>Heparin was administered at the dose of 2 mg/kg in the OPCAB group and 3 mg/kg in the CPB group, and the desired ACT was 350 s and 480 s, respectively. Postoperatively, heparin was neutralized by protamine administered at the dose of 1 mg per 1 mg of heparin.</p><p>The CPB group was subsequently subjected to the procedures of ascending aorta and right atrium cannulation. Cardiopulmonary bypass was conducted in moderate hypothermia (27-29&#x000b0;C) with cold, crystalloid cardioplegia administered antegrade in accordance with the St. Thomas Hospital formula.</p><p>In the OPCAB group, the Octopus III<sup>&#x000ae;</sup> (Medtronic, USA) stabilization system was used and intraluminal shunts were applied during each distal anastomosis.</p><p>Red packed cells were transfused whenever serum hemoglobin was lower than 6.5 mmol/L (&#x0003c; 10.5 g/dL).</p><sec id="S20003"><title>Statistical analysis</title><p>The obtained data were entered and analyzed using the StatView 5.0 software (SAS Institute, Inc., Cary, NC, USA). The normality of data distribution was assessed using the Kolmogorov-Smirnov test. Continuous variables were described as mean values &#x000b1; SD and compared using Student's <italic>t</italic>-test or the Mann-Whitney <italic>U</italic>-test. The &#x003c7;<sup><italic>2</italic></sup> test or Fisher's exact test was chosen to compare categorical variables. To evaluate changes over time, we used repeated measures analysis of variance (ANOVA). Values of <italic>p</italic> &#x0003c; 0.05 were considered significant.</p></sec></sec><sec sec-type="results" id="S0004"><title>Results</title><p>There were no perioperative deaths and no case of postoperative low cardiac syndrome was found in the study groups. There were 12 patients (14%) in the OPCAB who did not require any blood product transfusions. Two reoperations (2.4%) in the OPCAB group and three (4.4%) in the CPB group were performed due to excessive bleeding (<italic>p</italic> &#x0003c; 0.05). The mean cardiopulmonary bypass time was 63 &#x000b1; 18 minutes and the mean cross clamping time was 43 &#x000b1; 11 minutes in the CPB group.
</p><p>The mean packed red blood cells, fresh frozen plasma and platelet units transfused in the OPCAB group were 2.31 &#x000b1; 0.18, 1.13 &#x000b1; 0.13 and 0.28 &#x000b1; 0.16, respectively. The mean packed red blood cells, fresh frozen plasma and platelet units transfused in the CPB group were 3.94 &#x000b1; 0.30, 1.57 &#x000b1; 0.15 and 0.23 &#x000b1; 0.16, respectively. There was a statistically significant difference in the mean packed red blood cells (2.31 &#x000b1; 0.18 vs. 3.94 &#x000b1; 0.30, <italic>p</italic> &#x0003c; 0.05) and fresh frozen plasma (1.13 &#x000b1; 0.13 vs. 1.57 &#x000b1; 0.15, <italic>p</italic> &#x0003c; 0.05) transfusion rate between the groups.</p><p>There was a difference in the mean serum hemoglobin concentration between the groups (OPCAB 7.79 &#x000b1; 0.91 mmol/L vs. CPB 7.03 &#x000b1; 0.88 mmol/L six hours after surgery, <italic>p</italic> &#x0003c; 0.05 and OPCAB 7.47 &#x000b1; 1.10 mmol/L vs. CPB 7.17 &#x000b1; 0.99 mmol/L one day after surgery). <xref ref-type="fig" rid="F0001">Figure 1</xref> presents the differences in the serum hemoglobin concentration between the groups after surgery. The platelet count was comparable before the procedure (199 &#x000b1; 61 10<sup>3</sup>/L vs. 178 &#x000b1; 41 10<sup>3</sup>/L in the OPCAB and CPB group, respectively). The platelet count after surgery decreased progressively from 205 &#x000b1; 56 10<sup>3</sup>/L, 192 &#x000b1; 53 10<sup>3</sup>/L one day after surgery to 169 &#x000b1; 57 10<sup>3</sup>/L on the 7<sup>th</sup> postoperative day. On the other hand, the platelet count after surgery increased progressively in the CPB group from the initial 155 &#x000b1; 41 10<sup>3</sup>/L, 165 &#x000b1; 43 10<sup>3</sup>/L one day after surgery to 369 &#x000b1; 72 10<sup>3</sup>/L on the 7<sup>th</sup> postoperative day.</p><fig id="F0001" position="float"><label>Fig. 1</label><caption><p>Hemoglobin concentration after surgery in OPCAB and CPB group</p></caption><graphic xlink:href="KITP-11-23071-g001"/></fig><p>There was also a statistically significant difference in postoperative drainage between the two groups (OPCAB: 755.54 &#x000b1; 42.82 mL vs. CPB: 895.74 &#x000b1; 47.35 mL, <italic>p</italic> &#x0003c; 0.05).</p></sec><sec sec-type="discussion" id="S0005"><title>Discussion</title><p>The first successful use of the heart-lung machine on humans occurred in 1953, when John Gibbon performed surgery on a 15-month-old girl, Celia Bavolek, at Jefferson Hospital in Philadelphia [<xref rid="CIT0009" ref-type="bibr">9</xref>].</p><p>Eleven years later, in 1964, the Russian surgeon Kolessov performed the first successful heart bypass surgery on a beating heart [<xref rid="CIT0010" ref-type="bibr">10</xref>]. Surgical revascularization was soon demonstrated to provide excellent survival results and relief of symptoms [<xref rid="CIT0011" ref-type="bibr">11</xref>, <xref rid="CIT0012" ref-type="bibr">12</xref>].</p><p>Renewed interest in beating-heart bypass grafting in the mid-1990s resulted from the option of revascularization without the potential complications of extracorporeal support. Although the theoretical advantages of OPCAB procedures are generally accepted, the use of this technique still remains sporadic. For example, off-pump surgery constitutes only 20 to 25% of all coronary artery bypass procedures performed in the United States [<xref rid="CIT0013" ref-type="bibr">13</xref>].</p><p>A debatable issue is that of graft patency rates, which seem to be at least equivalent to those observed in the case of conventional techniques. The advantage of off-pump coronary artery bypass can be supported by such important factors as reduced morbidity and mortality, rapid return to usual functional capacity, and economic benefits. Unfortunately, a lot of data reported in the literature concerning the outcomes of off-pump bypass grafting have been inconclusive as to the overall benefit of the technique. Most studies have suffered from the fact that they have been retrospective reviews. Although the OPCAB technique eliminates cardiopulmonary bypass and hypothermic cardiac arrest, the manipulation of the ascending aorta by partial clamping has for the most part not been eliminated.</p><p>So far, there have been 37 randomized clinical trials published, comparing OPCAB versus conventional CABG. No randomized trials have shown a significant reduction in the occurrence of stroke or myocardial infarction, acute renal failure, intra-aortic balloon pump (IABP) requirement, mediastinitis or wound infection, the recurrence of angina, or the need for reintervention within 30 days of OPCAB, in comparison with conventional CABG [<xref rid="CIT0014" ref-type="bibr">14</xref>]. Similar results were obtained at 1 and 3 years after surgery [<xref rid="CIT0015" ref-type="bibr">15</xref>].</p><p>In the present study, there was a reduction of blood cell product transfusions in the OPCAB group, as compared to the CPB group (<xref ref-type="table" rid="T0002">Table II</xref>). OPCAB procedures make it possible not only to limit the number of transfusions but to eliminate transfusions altogether [<xref rid="CIT0016" ref-type="bibr">16</xref>, <xref rid="CIT0017" ref-type="bibr">17</xref>]. The elimination of blood product transfusion can be essential in the case of patients with religious restrictions, such as Jehovah witnesses [<xref rid="CIT0018" ref-type="bibr">18</xref>].</p><table-wrap id="T0002" position="float"><label>Tab. II</label><caption><p>Blood products transfusions</p></caption><table frame="hsides" rules="rows"><thead><tr><th align="left" rowspan="1" colspan="1">Blood products</th><th align="center" rowspan="1" colspan="1">OPCAB group</th><th align="center" rowspan="1" colspan="1">CABG group</th><th align="center" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Red cells (units)</td><td align="center" rowspan="1" colspan="1">2.31 &#x000b1; 0.2</td><td align="center" rowspan="1" colspan="1">3.94 &#x000b1; 0.3</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Fresh frozen plasma (units)</td><td align="center" rowspan="1" colspan="1">1.13 &#x000b1; 0.13</td><td align="center" rowspan="1" colspan="1">1.57 &#x000b1; 0.15</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Platelets (units)</td><td align="center" rowspan="1" colspan="1">0.28 &#x000b1; 0.16</td><td align="center" rowspan="1" colspan="1">0.23 &#x000b1; 0.16</td><td align="center" rowspan="1" colspan="1">ns</td></tr></tbody></table></table-wrap><p>The serum hemoglobin concentration in the OPCAB group remains stable throughout the postoperative period, as presented in <xref ref-type="table" rid="T0001">Table I</xref>. At the same time, we can observe a decline in the hemoglobin concentration in conventional CABG patients until the 12<sup>th</sup> postoperative hour. The restitution of the hematocrit level was achieved by administering packed red cell transfusions thereafter.</p></sec><sec sec-type="conclusions" id="S0006"><title>Conclusions</title><p>Off-pump surgery allows for reducing the rate of blood product transfusions or eliminating them altogether. The hematocrit level remained more stable during the postoperative period in the OPCAB group. Patients undergoing conventional CABG surgery were characterized by higher postoperative drainage, presumably due to more serious coagulation disturbances.</p></sec></body><back><bio id="d35e86"><p>
<inline-graphic xlink:href="KITP-11-23071-ig001.gif"/>
</p></bio><ref-list><title>References</title><ref id="CIT0001"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadowski</surname><given-names>J</given-names></name><name><surname>Kapelak</surname><given-names>B</given-names></name><name><surname>Wierzbicki</surname><given-names>K</given-names></name></person-group><article-title>Coronary artery disease &#x02013; classic and modern surgical treatment</article-title><source>Terapia</source><year>2003</year><volume>3</volume><fpage>4</fpage><lpage>8</lpage></element-citation></ref><ref id="CIT0002"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wites</surname><given-names>MM</given-names></name></person-group><article-title>Zastosowanie krwi i jej preparat&#x000f3;w w kardiochirurgii &#x02013; stan aktualny i kierunki rozwoju w oparciu o 20-letnie obserwacje kliniczne</article-title><source>Magazyn Medyczny</source><year>1999</year><volume>4</volume><fpage>13</fpage><lpage>14</lpage></element-citation></ref><ref id="CIT0003"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zych</surname><given-names>B</given-names></name><name><surname>Pacholewicz</surname><given-names>J</given-names></name><name><surname>Farmas</surname><given-names>A</given-names></name><name><surname>Saucha</surname><given-names>W</given-names></name><name><surname>Hrapkowicz</surname><given-names>T</given-names></name><name><surname>Zembala</surname><given-names>M</given-names></name></person-group><article-title>Operacje kardiochirurgiczne przetoczenia krwi i &#x0015b;rodk&#x000f3;w krwiopochodnych</article-title><source>Kardichir Torakochir Pol</source><year>2004</year><volume>1</volume><fpage>31</fpage><lpage>40</lpage></element-citation></ref><ref id="CIT0004"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogowski</surname><given-names>J</given-names></name><name><surname>Jarmoszewicz</surname><given-names>K</given-names></name><name><surname>Siondalski</surname><given-names>P</given-names></name><name><surname>Pawlaczyk</surname><given-names>R</given-names></name></person-group><article-title>Opieka pooperacyjna po zabiegach kardiochirurgicznych</article-title><source>Choroby Serca i Naczy&#x00144;</source><year>2006</year><volume>3</volume><fpage>115</fpage><lpage>122</lpage></element-citation></ref><ref id="CIT0005"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suwalski</surname><given-names>G</given-names></name><name><surname>Filipiak</surname><given-names>KJ</given-names></name></person-group><article-title>Uog&#x000f3;lniona odpowied&#x0017a; zapalna u chorych poddanych zabiegom chirurgicznej rewaskularyzacji mi&#x00119;&#x0015b;nia sercowego</article-title><source>Polski Przegl&#x00105;d Kardiologiczny</source><year>2002</year><volume>4</volume><fpage>259</fpage><lpage>266</lpage></element-citation></ref><ref id="CIT0006"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ascione</surname><given-names>R</given-names></name><name><surname>Lloyd</surname><given-names>CT</given-names></name><name><surname>Underwood</surname><given-names>MJ</given-names></name><name><surname>Lotto</surname><given-names>AA</given-names></name><name><surname>Pitsis</surname><given-names>AA</given-names></name><name><surname>Angelini</surname><given-names>GD</given-names></name></person-group><article-title>Inflammatory response after coronary revasscularization with or without cardiopulmonary by-pass</article-title><source>Ann Thorac Surg</source><year>2000</year><volume>69</volume><fpage>1198</fpage><lpage>1204</lpage><pub-id pub-id-type="pmid">10800819</pub-id></element-citation></ref><ref id="CIT0007"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khuri</surname><given-names>S</given-names></name><name><surname>Wolfe</surname><given-names>JA</given-names></name><name><surname>Josa</surname><given-names>M</given-names></name><name><surname>Axford</surname><given-names>TC</given-names></name><name><surname>Szymanski</surname><given-names>I</given-names></name><name><surname>Assousa</surname><given-names>S</given-names></name><name><surname>Ragno</surname><given-names>G</given-names></name><name><surname>Patel</surname><given-names>M</given-names></name><name><surname>Silverman</surname><given-names>A</given-names></name><name><surname>Park</surname><given-names>M</given-names></name></person-group><article-title>Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss</article-title><source>J Thorac Cardiovasc Surg</source><year>1992</year><volume>104</volume><fpage>94</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">1614220</pub-id></element-citation></ref><ref id="CIT0008"><label>8</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Czapla</surname><given-names>J</given-names></name><name><surname>Skalski</surname><given-names>JH</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Tom</surname><given-names>I</given-names></name><name><surname>Skalski</surname><given-names>J</given-names></name><name><surname>Religa</surname><given-names>A</given-names></name></person-group><article-title>Zaburzenia hemostazy w kardiochirurgii</article-title><source>Kardiochirurgia dzieci&#x00119;ca</source><year>2003</year><publisher-loc>Katowice</publisher-loc><publisher-name>Wydawnictwo &#x0015a;l&#x00105;sk</publisher-name><fpage>96</fpage><lpage>309</lpage></element-citation></ref><ref id="CIT0009"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbon</surname><given-names>JH</given-names><suffix>Jr</suffix></name></person-group><article-title>Application of a mechanical heart and lung apparatusto cardiac surgery</article-title><source>Minn Med</source><year>1954</year><volume>37</volume><fpage>171</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">13154149</pub-id></element-citation></ref><ref id="CIT0010"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolessov</surname><given-names>VI</given-names></name></person-group><article-title>Mammary artery-coronary artery anastomosis as method of treatment for angina pectoris</article-title><source>J Thorac Cardiovasc Surg</source><year>1967</year><volume>54</volume><fpage>535</fpage><lpage>544</lpage><pub-id pub-id-type="pmid">6051440</pub-id></element-citation></ref><ref id="CIT0011"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>European Coronary Surgery Study Group</collab></person-group><article-title>Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. European Coronary Surgery Study Group</article-title><source>Lancet</source><year>1982</year><volume>2</volume><fpage>1173</fpage><lpage>1180</lpage><pub-id pub-id-type="pmid">6128492</pub-id></element-citation></ref><ref id="CIT0012"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group</collab></person-group><article-title>Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina</article-title><source>N Engl J Med</source><year>1984</year><volume>311</volume><fpage>133</fpage><lpage>139</lpage></element-citation></ref><ref id="CIT0013"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lytle</surname><given-names>BW</given-names></name><name><surname>Sabik</surname><given-names>JF</given-names></name></person-group><article-title>On-pump and off-pump bypass surgery: Tools for revascularization</article-title><source>Circulation</source><year>2004</year><volume>109</volume><fpage>810</fpage><lpage>812</lpage><pub-id pub-id-type="pmid">14981010</pub-id></element-citation></ref><ref id="CIT0014"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sellke</surname><given-names>FW</given-names></name><name><surname>DiMaio</surname><given-names>JM</given-names></name><name><surname>Caplan</surname><given-names>LR</given-names></name><name><surname>Ferguson</surname><given-names>TB</given-names></name><name><surname>Gardner</surname><given-names>TJ</given-names></name><name><surname>Hiratzka</surname><given-names>LF</given-names></name><name><surname>Isselbacher</surname><given-names>EM</given-names></name><name><surname>Lytle</surname><given-names>BW</given-names></name><name><surname>Mack</surname><given-names>MJ</given-names></name><name><surname>Murkin</surname><given-names>JM</given-names></name><name><surname>Robbins</surname><given-names>RC</given-names></name></person-group><article-title>Comparing onpump vs off-pump coronary artery bypass grafting: Numerous studies but fewer conclusions</article-title><source>Circulation</source><year>2005</year><volume>111</volume><fpage>2858</fpage><lpage>2864</lpage><pub-id pub-id-type="pmid">15927994</pub-id></element-citation></ref><ref id="CIT0015"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reston</surname><given-names>JT</given-names></name><name><surname>Tregear</surname><given-names>SJ</given-names></name><name><surname>Turkelson</surname><given-names>CM</given-names></name></person-group><article-title>Meta-analysis of short-term and midterm outcomes following off-pump coronary artery bypass grafting</article-title><source>Ann Thorac Surg</source><year>2003</year><volume>76</volume><fpage>1510</fpage><lpage>1515</lpage><pub-id pub-id-type="pmid">14602277</pub-id></element-citation></ref><ref id="CIT0016"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angelini</surname><given-names>GD</given-names></name><name><surname>Taylor</surname><given-names>FC</given-names></name><name><surname>Reeves</surname><given-names>BC</given-names></name><name><surname>Asciore</surname><given-names>R</given-names></name></person-group><article-title>Early and midterm outcome after off-pump and on-pump surgery. In Beating Heart Against Cardioplegic Arrest Studies (BHACAS 1 and 2): a pooled analysis of two randomised controlled trials</article-title><source>Lancet</source><year>2002</year><volume>359</volume><fpage>1194</fpage><lpage>1199</lpage><pub-id pub-id-type="pmid">11955537</pub-id></element-citation></ref><ref id="CIT0017"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacGilivrary</surname><given-names>TE</given-names></name><name><surname>Vlahakes</surname><given-names>GJ</given-names></name></person-group><article-title>Patency and the pump &#x02013; the risk and benefis of off-pump CABG</article-title><source>N Engl J Med</source><year>2004</year><volume>1</volume><fpage>3</fpage><lpage>4</lpage></element-citation></ref><ref id="CIT0018"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juraszek</surname><given-names>A</given-names></name><name><surname>Dziodzio</surname><given-names>T</given-names></name><name><surname>Roedler</surname><given-names>S</given-names></name><name><surname>Kral</surname><given-names>A</given-names></name><name><surname>Hutschala</surname><given-names>D</given-names></name><name><surname>Wolner</surname><given-names>E</given-names></name><name><surname>Grimm</surname><given-names>M</given-names></name><name><surname>Czerny</surname><given-names>M</given-names></name></person-group><article-title>Results of open heart surgery in Jehovah's Witnesses patients</article-title><source>J Cardiovasc Surg</source><year>2009</year><volume>50</volume><fpage>247</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">19329922</pub-id></element-citation></ref></ref-list></back></article>